SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 63 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $867,000 | +182.4% | 79,000 | +125.7% | 0.02% | +400.0% |
| Q4 2019 | $307,000 | +17.6% | 35,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $261,000 | -19.9% | 35,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $326,000 | -60.4% | 35,000 | -65.6% | 0.00% | -50.0% |
| Q3 2018 | $823,000 | +131.8% | 101,800 | +101.6% | 0.01% | +100.0% |
| Q2 2018 | $355,000 | -50.6% | 50,500 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $719,000 | +62.7% | 50,500 | 0.0% | 0.01% | +60.0% |
| Q4 2017 | $442,000 | -25.2% | 50,500 | 0.0% | 0.01% | -28.6% |
| Q3 2017 | $591,000 | -16.2% | 50,500 | 0.0% | 0.01% | -12.5% |
| Q2 2017 | $705,000 | +1.7% | 50,500 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $693,000 | – | 50,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
| Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
| Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
| BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
| FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
| Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
| Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
| PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |